Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 2
1990 2
1991 1
1997 3
1998 2
1999 5
2000 4
2001 2
2002 4
2003 3
2004 4
2005 3
2006 2
2007 4
2008 4
2009 7
2010 5
2011 6
2012 10
2013 6
2014 4
2015 11
2016 11
2017 13
2018 17
2019 9
2020 9
2021 10
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

167 results
Results by year
Filters applied: . Clear all
Page 1
PSMA Theranostics: Current Status and Future Directions.
Rahbar K, Afshar-Oromieh A, Jadvar H, Ahmadzadehfar H. Rahbar K, et al. Among authors: jadvar h. Mol Imaging. 2018 Jan-Dec;17:1536012118776068. doi: 10.1177/1536012118776068. Mol Imaging. 2018. PMID: 29873291 Free PMC article. Review.
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.
Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. Calais J, et al. Among authors: jadvar h. Lancet Oncol. 2019 Sep;20(9):1286-1294. doi: 10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30. Lancet Oncol. 2019. PMID: 31375469 Free PMC article. Clinical Trial.
Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.
Jadvar H, Calais J, Fanti S, Feng F, Greene KL, Gulley JL, Hofman M, Koontz BF, Lin DW, Morris MJ, Rowe SP, Royce TJ, Salami S, Savir-Baruch B, Srinivas S, Hope TA. Jadvar H, et al. J Nucl Med. 2022 Jan;63(1):59-68. doi: 10.2967/jnumed.121.263262. Epub 2021 Sep 30. J Nucl Med. 2022. PMID: 34593595 Free PMC article. No abstract available.
Prostate cancer.
Jadvar H. Jadvar H. Methods Mol Biol. 2011;727:265-90. doi: 10.1007/978-1-61779-062-1_15. Methods Mol Biol. 2011. PMID: 21331939 Review.
Editorial Comment.
Luis de Castro Abreu A, Jadvar H. Luis de Castro Abreu A, et al. Among authors: jadvar h. J Urol. 2019 Aug;202(2):420-421. doi: 10.1097/01.JU.0000559889.09039.c1. Epub 2019 Jul 8. J Urol. 2019. PMID: 31094671 No abstract available.
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline.
Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA. Trabulsi EJ, et al. Among authors: jadvar h. J Clin Oncol. 2020 Jun 10;38(17):1963-1996. doi: 10.1200/JCO.19.02757. Epub 2020 Jan 15. J Clin Oncol. 2020. PMID: 31940221
Targeted α-therapy in non-prostate malignancies.
Jadvar H, Colletti PM. Jadvar H, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):47-53. doi: 10.1007/s00259-021-05405-0. Epub 2021 May 16. Eur J Nucl Med Mol Imaging. 2021. PMID: 33993386 Review.
Musculoskeletal system.
Jadvar H, Gamie S, Ramanna L, Conti PS. Jadvar H, et al. Semin Nucl Med. 2004 Oct;34(4):254-61. doi: 10.1053/j.semnuclmed.2004.06.002. Semin Nucl Med. 2004. PMID: 15493003 Review.
Radiotheranostics in Cancer Diagnosis and Management.
Jadvar H, Chen X, Cai W, Mahmood U. Jadvar H, et al. Radiology. 2018 Feb;286(2):388-400. doi: 10.1148/radiol.2017170346. Radiology. 2018. PMID: 29356634 Free PMC article. Review.
167 results